Tetravalent Dengue Vaccine Reduces Symptomatic and Asymptomatic Dengue Virus Infections in Healthy Children and Adolescents Aged 2-16 Years in Asia and Latin America.
Saved in:
| Title: | Tetravalent Dengue Vaccine Reduces Symptomatic and Asymptomatic Dengue Virus Infections in Healthy Children and Adolescents Aged 2-16 Years in Asia and Latin America. |
|---|---|
| Authors: | Olivera-Botello G; Sanofi Pasteur, Lyon., Coudeville L; Sanofi Pasteur, Lyon., Fanouillere K; Sanofi, Chilly-Mazarin Cedex., Guy B; Sanofi Pasteur, Lyon., Chambonneau L; Sanofi Pasteur, Marcy l'Etoile, France., Noriega F; Sanofi Pasteur, Swiftwater, Pennsylvania., Jackson N; Sanofi Pasteur, Marcy l'Etoile, France. |
| Corporate Authors: | CYD-TDV Vaccine Trial Group |
| Source: | The Journal of infectious diseases [J Infect Dis] 2016 Oct 01; Vol. 214 (7), pp. 994-1000. Date of Electronic Publication: 2016 Jul 14. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
